Celldex Therapeutics (CLDX) Q3 2023 Earnings

8AugConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.67
-0.63
-0.6
-0.56

Details

Expected EPS
-0.67
Actual EPS
-0.65
Surprise EPS
0.02
Surprise Percent
+2.99%

Description

Celldex Therapeutics (CLDX) has reported earnings of -0.65 per share for Q3 2023.

0 Comments

Share your thoughts